Cardiovascular Health

Six patient deaths and other serious adverse events have been linked to SentreHeart's Lariat Suture Delivery Device, the FDA is warning health care professionals.

Here are new drugs for 2015 that pharmacists can expect to handle.

The FDA today approved sacubitril/valsartan for treating heart failure.

A practice-changing study suggests bridging anticoagulation does more harm than good in atrial fibrillation (AF) patients treated with warfarin.

Studies have reported that up to half of patients discontinue prescribed therapies soon after hospital discharge.

The FDA today approved The Medicines Company's cangrelor (Kengreal), an intravenous antiplatelet medication that can prevent blood clots from forming in the coronary arteries.

Women with diabetes have a considerably higher risk of developing coronary heart disease than men with diabetes.

Many common Cardiovascular Disease risk factors, such as hypertension, high cholesterol, type 2 diabetes, and thrombosis, are often experienced by women after a spontaneous preterm delivery.

Here are new drugs for 2015 pharmacists can expect to handle.

A study evaluating the cardiovascular safety of Merck's type 2 diabetes drug sitagliptin determined the dipeptidyl peptidase-4 inhibitor does not increase the risk for heart failure hospitalization.

FDA officials have recommended approval for Amgen's proposed cholesterol-lowering medication, evolocumab (Repatha).

Pharmacists know changes in vitamin K intake can drastically alter INR values in patients taking warfarin.

Recent research findings may help health care professionals participating in a new Affordable Care Act payment model identify patients at greatest risk for cardiovascular disease (CVD).

While statins are among the most commonly prescribed medications for the prevention of cardiovascular disease, a recent study suggests that the use of statins may increase a patient's risk of developing cataracts.

The Arctic Front Advance ST Cryoablation Catheter is approved for use in patients with drug refractory, recurrent, symptomatic paroxysmal atrial fibrillation.

Since no medications or surgical procedures are available to treat cardiovascular calcification, clinicians generally recommend lifestyle changes.

A new prognostic model could help clinicians prioritize risk factors in heart failure patients.

Despite being told the importance of medication adherence, about half of acute coronary syndrome patients don't take their oral antiplatelet therapy as prescribed.

The FDA has granted priority review to expand the use of AstraZeneca's ticagrelor (Brilinta).

Thiazide diuretics are the least expensive antihypertensive drugs available in most countries.

Here are the key points and rationale behind the lower blood pressure target.

The drug is indicated for cardiac event prophylaxis or treatment in adult patients in the United States with heparin-induced thrombocytopenia.

The JNC 8 guidelines are based on 27 large clinical trials that are often discussed in isolation, but have never been aggregated into a single source until now.

A new cardiovascular risk estimator can accurately predict heart disease and stroke risk for anyone in the world aged 40 years or older.

While the FDA only recommends daily aspirin for patients who have experienced major cardiovascular events, about half of older adults in the United States take aspirin regularly.